Pharma News, 2019

JERUSALEM, Nov.

SAN DIEGO--(BUSINESS WIRE)--COI Pharmaceuticals, the Community Of Innovation established by Avalon Ventures, today announced the acquisition of Calporta Therapeutics, Inc.

AstraZeneca is planning to file for approval of anifrolumab in systemic lupus erythematosus (SLE) in the second half of next year.

A state-of-the-art fingerprint detection technology can identify traces of heroin on human skin, even after someone has washed their hands - and it is also smart enough to tell whether an individual h...

OTTAWA, Nov.

In some cases, AI-assisted cancer detection might be more than a convenience -- it could be the key to getting a diagnosis in the first place.

Basel, 11 November 2019 – Roche (SIX.

The P-III program involves assessing of Roxadustat vs PBO and epoetin alfa in 9,000+ NDD and DD & ID patients in multiple studies conducted by AstraZeneca, FibroGen and Astellas together globa...

Today, the European Commission adopted the decision granting marketing authorisation to the company Merck Sharp & Dohme B.

The FDA has accepted the supplemental biologics license application and granted breakthrough therapy designation to nivolumab (Opdivo) plus ipilimumab (Yervoy) for the treatment of pat...

Roche has discontinued a phase 2/3 trial of RG6206 after a futility analysis showed that the drug was “highly unlikely” to demonstrate clinical benefit in patients with Duchenne muscular dystrophy...

Novo Nordisk A/S and UBE Industries Ltd.